EDGAR Filing Documents for 0001279569-15-000716

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001279569-15-000716

Filing Date

2015-04-14

Accepted

2015-04-14 12:25:29

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	v407131_20f.htm	20-F	1656279
2	EXHIBIT 4.29	v407131_ex4-29.htm	EX-4.29	54891
3	EXHIBIT 12.1	v407131_ex12-1.htm	EX-12.1	8571
4	EXHIBIT 12.2	v407131_ex12-2.htm	EX-12.2	8607
5	EXHIBIT 13.1	v407131_ex13-1.htm	EX-13.1	6180
6	EXHIBIT 23.1	v407131_ex23-1.htm	EX-23.1	6215
7	GRAPHIC	tpg123.jpg	GRAPHIC	5799
	Complete submission text file	0001279569-15-000716.txt		1749844

Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6

Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412

MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 15768686
SIC: 2834 Pharmaceutical Preparations